Cugini P, Gasbarrone L, Lucia P, Cianetti A, Canova R, Di Palma L, Sepe F A, Pozzilli P, Scibilia G, Cioli A R
Istituto di Clinica Medica II, Università degli Studi La Sapienza, Roma.
Cardiologia. 1992 Oct;37(10):693-9.
Vasoactive intestinal peptide (VIP) is released both by neural endings and lymphocytes. Aim of our investigation was to study the effects of immunosuppressive therapy on VIP plasma concentrations. The research has been performed on 10 heart transplanted patients assuming cyclosporine (CYCL) and prednisone (PRED). The circulating T lymphocyte subsets, atrial natriuretic peptide (ANP), plasma renin activity (PRA), plasma aldosterone (PA) and plasma cortisol (PC) have been also assayed. Blood pressure (BP) and heart rate (HR) have been monitored over a 24-hour period to detect whether circulating VIP in heart transplanted patients is influenced by pharmacologically-induced interactions. Seriate samplings along the 24-hour span have been performed. Mean values of ANP, PRA and PA were increased, while VIP, PC and T lymphocyte subsets were decreased in heart transplanted patients as compared to clinically healthy subjects. ANOVA and Cosinor analysis showed, respectively, a statistically significant 24-hour variability and circadian rhythm for all the investigated variables only in normal subjects. BP and HR circadian rhythm in heart transplanted patients suggest that the adrenergic activity regulating the cardiovascular system is restored. This finding argues that the reduction in VIP plasma concentrations is likely due to the decreased lymphocyte production secondary to immunosuppressive therapy, or can also be ascribed to the inhibiting action of high circulating levels of ANP.
血管活性肠肽(VIP)由神经末梢和淋巴细胞释放。我们研究的目的是探讨免疫抑制治疗对血浆VIP浓度的影响。本研究对10例接受环孢素(CYCL)和泼尼松(PRED)治疗的心脏移植患者进行。同时还检测了循环T淋巴细胞亚群、心房利钠肽(ANP)、血浆肾素活性(PRA)、血浆醛固酮(PA)和血浆皮质醇(PC)。在24小时内监测血压(BP)和心率(HR),以检测心脏移植患者循环中的VIP是否受到药物诱导相互作用的影响。在24小时内进行了系列采样。与临床健康受试者相比,心脏移植患者的ANP、PRA和PA平均值升高,而VIP、PC和T淋巴细胞亚群降低。方差分析和余弦分析分别显示,仅在正常受试者中,所有研究变量均有统计学意义的24小时变异性和昼夜节律。心脏移植患者的BP和HR昼夜节律表明调节心血管系统的肾上腺素能活性得以恢复。这一发现表明,血浆VIP浓度降低可能是由于免疫抑制治疗导致淋巴细胞生成减少,也可能归因于循环中高水平ANP的抑制作用。